Literature DB >> 23453244

Residual neuromuscular block as a risk factor for critical respiratory events in the post anesthesia care unit.

M Norton1, D Xará, D Parente, M Barbosa, F J Abelha.   

Abstract

OBJECTIVE: Residual neuromuscular block is an important postoperative complication associated to the use of neuromuscular blocking drugs. The purpose of this study was to access the incidence of residual neuromuscular block in a post-anesthesia care unit and to evaluate its association with critical respiratory events.
MATERIAL AND METHODS: Prospective cohort study was conducted in a Post Anesthetic Care Unit (PACU) for a period of 3 weeks. Two hundred two adult patients who submitted to scheduled non-cardiac and non-intracranial surgery were eligible to the study. The primary outcome variable was residual neuromuscular block after arrival to PACU that was defined as train-of-four ratio <0.9 and objectively quantified using acceleromyography. Demographic data, perioperative variables, lengths of hospital and recovery room stay and critical respiratory events were recorded. Inadequate emergence was classified in its different forms according to the Richmond agitation and sedation scale 10 min after admission to the recovery room.
RESULTS: Residual neuromuscular block incidence in the post-anesthesia care unit was 29.7% (95% confidence interval: 23.4, 36.1). Patients with residual neuromuscular block had more frequently overall critical respiratory events (51% versus 16%, P<0.001), airway obstruction (10% versus 2%, P=0.029), mild-moderate hypoxemia (23% versus 4%, P<0.001), severe hypoxemia (7% versus 1%, P=0.033), respiratory failure (8% versus 1%, P=0.031), inability to breathe deeply (38% versus 12%, P<0.001) and muscular weakness (16% versus 1%, P<0.001). Residual neuromuscular block was more common after high-risk surgery (53% versus 33%, P=0.011) and was more often associated with post-operative hypoactive emergence as defined by the Richmond Agitation and Sedation Scale (21% versus 6%, P=0.001).
CONCLUSIONS: This study suggests that residual neuromuscular block is common in the PACU and is associated with more frequent critical respiratory events.
Copyright © 2012 Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor. Published by Elsevier España. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23453244     DOI: 10.1016/j.redar.2012.12.011

Source DB:  PubMed          Journal:  Rev Esp Anestesiol Reanim        ISSN: 0034-9356


  5 in total

1.  Central hyperventilation syndrome due to massive pneumocephalus after endoscopic third ventriculostomy: a case report.

Authors:  Euiseok Park; Heezoo Kim; Byung Gun Lim; Dong Kyu Lee; Dongik Chung
Journal:  Korean J Anesthesiol       Date:  2016-07-01

2.  A discrete event simulation model of clinical and operating room efficiency outcomes of sugammadex versus neostigmine for neuromuscular block reversal in Canada.

Authors:  Ralph P Insinga; Cédric Joyal; Alexandra Goyette; André Galarneau
Journal:  BMC Anesthesiol       Date:  2016-11-16       Impact factor: 2.217

3.  Economic analysis of sugammadex versus neostigmine for reversal of neuromuscular blockade for laparoscopic surgery in China.

Authors:  Maodong Ren; Ying Wang; Yan Luo; Jia Fang; Yongji Lu; Jianwei Xuan
Journal:  Health Econ Rev       Date:  2020-11-14

4.  The association between residual neuromuscular blockade (RNMB) and critical respiratory events: a prospective cohort study.

Authors:  Faraj K Alenezi; Khalid Alnababtah; Mohammed M Alqahtani; Lafi Olayan; Mohammed Alharbi
Journal:  Perioper Med (Lond)       Date:  2021-05-04

5.  Does sugammadex decrease the severity of agitation and complications in pediatric patients undergoing adenotonsillectomy?

Authors:  Muge O Korkmaz; Havva Sayhan; Mehmet Guven
Journal:  Saudi Med J       Date:  2019-09       Impact factor: 1.484

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.